923 results on '"Amant, Frederic"'
Search Results
2. Prenatal cell-free DNA testing of women with pregnancy-associated cancer: a retrospective cross-sectional study
3. Reproductive, obstetrical and oncological outcomes of fertility-sparing treatment for cervical cancer according to the FIGO 2018 staging system: A systematic review
4. Preferences and considerations for interval cytoreductive surgery in advanced ovarian cancer: The patient's perspective
5. Long-term neurocognitive, psychosocial, and physical outcomes after prenatal exposure to radiotherapy: a multicentre cohort study of the International Network on Cancer, Infertility, and Pregnancy
6. Practice patterns, time trends and quality of care of uterine cancer in Belgium: An analysis of the EFFECT database
7. Cross-Cancer Genome-Wide Association Study of Endometrial Cancer and Epithelial Ovarian Cancer Identifies Genetic Risk Regions Associated with Risk of Both Cancers
8. Cross-cancer genome-wide association study of endometrial cancer and epithelial ovarian cancer identifies genetic risk regions associated with risk of both cancers
9. Multi-trait genome-wide association study identifies a novel endometrial cancer risk locus that associates with testosterone levels
10. Direct and indirect effects on child neurocognitive development when maternal cancer is diagnosed during pregnancy: What do we know so far?
11. Loss of skeletal muscle density during neoadjuvant chemotherapy in older women with advanced stage ovarian cancer is associated with postoperative complications
12. High expression of phosphoglycerate dehydrogenase predicts poor outcome in patients with high-grade serous ovarian cancer.
13. MetDecode: methylation-based deconvolution of cell-free DNA for noninvasive multi-cancer typing.
14. Immunotherapy for cancer treatment during pregnancy
15. Evaluating offspring Genomic and Epigenomic alterations after prenatal exposure to Cancer treatment In Pregnancy (GE-CIP): a multicentric observational study
16. Management of Rare Uterine Malignant Tumors
17. Surgical Principles of Endometrial Cancer
18. Pregnancy After Gynecological Cancer
19. Optimization of the clofazimine structure leads to a highly water-soluble C3-aminopyridinyl riminophenazine endowed with improved anti-Wnt and anti-cancer activity in vitro and in vivo
20. Low preoperative skeletal muscle density is predictive for negative postoperative outcomes in older women with ovarian cancer
21. Childhood Ovarian Cancers
22. Comprehensive genome-wide analysis of routine non-invasive test data allows cancer prediction: A single-center retrospective analysis of over 85,000 pregnancies
23. Population Pharmacokinetics of Docetaxel, Paclitaxel, Doxorubicin and Epirubicin in Pregnant Women with Cancer: A Study from the International Network of Cancer, Infertility and Pregnancy (INCIP)
24. Angiogenesis in gynecological cancers and the options for anti-angiogenesis therapy
25. Splenic 18F-FDG uptake on baseline PET/CT is associated with oncological outcomes and tumor immune state in uterine cervical cancer
26. Long‐term outcomes of children after prenatal exposure to maternal cancer and its treatment
27. CYP19A1 fine-mapping and Mendelian randomization: estradiol is causal for endometrial cancer
28. Common variants at 19p13 are associated with susceptibility to ovarian cancer (vol 42, pg 880, 2010)
29. Corrigendum: Common variants at 19p13 are associated with susceptibility to ovarian cancer.
30. Meta-analysis of genome-wide association studies identifies common susceptibility polymorphisms for colorectal and endometrial cancer near SH2B3 and TSHZ1.
31. Fine-mapping of the HNF1B multicancer locus identifies candidate variants that mediate endometrial cancer risk
32. Candidate locus analysis of the TERT–CLPTM1L cancer risk region on chromosome 5p15 identifies multiple independent variants associated with endometrial cancer risk
33. Obstetric and maternal outcomes in patients diagnosed with Hodgkin lymphoma during pregnancy: a multicentre, retrospective, cohort study
34. Long-term impact of prenatal exposure to chemotherapy on executive functioning: An ERP study
35. PARAGON: A Phase II study of anastrozole in patients with estrogen receptor-positive recurrent/metastatic low-grade ovarian cancers and serous borderline ovarian tumors
36. Phase 2 study of anastrozole in recurrent estrogen (ER)/progesterone (PR) positive endometrial cancer: The PARAGON trial – ANZGOG 0903
37. Challenges and opportunities for proton therapy during pregnancy.
38. #447 Comparison between immunohistochemical-based model and genomic profiling in endometrial cancer molecular stratification: a propensity-matched survival analysis
39. Breast Cancer (Diagnosed) During Pregnancy: Adapting Recent Advances in Breast Cancer Care for Pregnant Patients
40. Genome profiling is an efficient tool to avoid the STUMP classification of uterine smooth muscle lesions: a comprehensive array-genomic hybridization analysis of 77 tumors
41. Acute Drug Effects on the Human Placental Tissue: The Development of a Placental Murine Xenograft Model
42. Polymorphisms in Stromal Genes and Susceptibility to Serous Epithelial Ovarian Cancer: A Report from the Ovarian Cancer Association Consortium
43. Common variants at 19p13 are associated with susceptibility to ovarian cancer.
44. Challenges and opportunities for proton therapy during pregnancy
45. Neonatal and Long-Term Consequences of In Utero Exposure to Systemic Anticancer Therapy
46. Integration and validation of the ex vivo human placenta perfusion model
47. Diagnostic value of whole body diffusion-weighted MRI compared to computed tomography for pre-operative assessment of patients suspected for ovarian cancer
48. Establishment and characterization of uterine sarcoma and carcinosarcoma patient-derived xenograft models
49. Pregnancy After Gynecological Cancer
50. Surgical Principles of Endometrial Cancer
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.